PI
Pennant Investors Portfolio holdings
AUM $334M
1-Year Return
56.91%
This Quarter Return
+9.86%
1 Year Return
+56.91%
3 Year Return
+148.85%
5 Year Return
+226.03%
10 Year Return
–
AUM
$325M
AUM Growth
+$61.3M
(+23%)
Cap. Flow
+$27.7M
Cap. Flow
% of AUM
8.52%
Top 10 Holdings %
Top 10 Hldgs %
96.2%
Holding
44
New
31
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
EchoStar
SATS
|
+$35.7M |
| 2 |
Perimeter Solutions
PRM
|
+$3.22M |
| 3 |
Altimmune
ALT
|
+$1.24M |
| 4 |
FibroGen
FGEN
|
+$681K |
| 5 |
Nurix Therapeutics
NRIX
|
+$586K |
Top Sells
| 1 |
DISH
DISH Network Corp.
DISH
|
+$24.3M |
Sector Composition
| 1 | Communication Services | 27.06% |
| 2 | Consumer Discretionary | 23.17% |
| 3 | Technology | 22.96% |
| 4 | Industrials | 13.15% |
| 5 | Energy | 6.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.47T
| $52.9M | 11.54% |
348,000
| – | – |
|
2
Alphabet (Google) Class A
GOOGL
$3.04T
| $52.4M | 11.44% |
375,000
| – | – |
|
3
Microsoft
MSFT
$3.83T
| $48.5M | 10.59% |
129,000
| – | – |
|
4
TransDigm Group
TDG
$72.6B
| $42.5M | 9.28% |
42,000
| – | – |
|
|
5
EchoStar
SATS
$20.7B
| $35.7M | 7.79% |
+2,153,209
| New | +$35.7M |
|
6
Micron Technology
MU
$177B
| $26.1M | 5.7% |
306,000
| – | – |
|
7
ODP
ODP
$616M
| $22.5M | 4.92% |
400,000
| – | – |
|
8
Antero Resources
AR
$10B
| $20.7M | 4.52% |
913,000
| – | – |
|
|
9
Perimeter Solutions
PRM
$3.28B
| $10.6M | 2.31% |
2,300,000
+700,000
| +44% | +$3.22M |
|
|
10
Altimmune
ALT
$317M
| $1.24M | 0.27% |
+109,800
| New | +$1.24M |
|
|
11
FibroGen
FGEN
$47.9M
| $681K | 0.15% |
+30,736
| New | +$681K |
|
|
12
Nurix Therapeutics
NRIX
$663M
| $586K | 0.13% |
+56,800
| New | +$586K |
|
13
Coherus Oncology, Inc. Common Stock
CHRS
$148M
| $560K | 0.12% |
+168,100
| New | +$560K |
|
14
Arcutis Biotherapeutics
ARQT
$2.03B
| $552K | 0.12% |
+170,900
| New | +$552K |
|
15
Fate Therapeutics
FATE
$110M
| $546K | 0.12% |
+146,100
| New | +$546K |
|
|
IGMS
16
DELISTED
IGM Biosciences
IGMS
| $539K | 0.12% |
+64,900
| New | +$539K |
|
|
ALLK
17
DELISTED
Allakos
ALLK
| $508K | 0.11% |
+186,100
| New | +$508K |
|
18
Travere Therapeutics
TVTX
$2.05B
| $502K | 0.11% |
+55,800
| New | +$502K |
|
19
89bio
ETNB
$1.19B
| $497K | 0.11% |
+44,500
| New | +$497K |
|
20
Zentalis Pharmaceuticals
ZNTL
$105M
| $491K | 0.11% |
+32,400
| New | +$491K |
|
21
Relay Therapeutics
RLAY
$700M
| $467K | 0.1% |
+42,400
| New | +$467K |
|
22
Arcus Biosciences
RCUS
$1.23B
| $453K | 0.1% |
+23,700
| New | +$453K |
|
23
MacroGenics
MGNX
$98.6M
| $421K | 0.09% |
+43,800
| New | +$421K |
|
24
Arcturus Therapeutics
ARCT
$492M
| $413K | 0.09% |
+13,100
| New | +$413K |
|
25
Allogene Therapeutics
ALLO
$255M
| $412K | 0.09% |
+128,400
| New | +$412K |
|